Moreover, blueberry supplementation has been shown to decrease monocyte expression of monocyte-to-macrophage differentiation-associated (MMD) and C-C motif chemokine receptor 2 (CCR2), reducing inflammation in metabolic syndrome patients (140). Here, CCR2 is linked to metabolic syndrome.